IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 35 filers reported holding IKENA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,858,421 | -18.5% | 1,352,984 | +23.5% | 0.00% | – |
| Q2 2023 | $7,184,315 | +108.5% | 1,095,170 | +9.7% | 0.00% | – |
| Q1 2023 | $3,445,128 | +32.2% | 998,588 | +1.9% | 0.00% | – |
| Q4 2022 | $2,605,515 | -25.0% | 979,517 | +0.1% | 0.00% | – |
| Q3 2022 | $3,475,000 | +16.3% | 979,003 | +45.2% | 0.00% | – |
| Q2 2022 | $2,987,000 | -38.0% | 674,105 | -14.7% | 0.00% | – |
| Q1 2022 | $4,819,000 | -50.9% | 789,999 | +1.0% | 0.00% | – |
| Q4 2021 | $9,811,000 | +25.3% | 782,394 | +26.1% | 0.00% | – |
| Q3 2021 | $7,833,000 | +69.8% | 620,686 | +88.9% | 0.00% | – |
| Q2 2021 | $4,613,000 | +172.2% | 328,612 | +447.7% | 0.00% | – |
| Q1 2021 | $1,695,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |